iCARE DOA 10 Panels Rapid Screen Test (Configurable) – Ensuring Accuracy in Drug Testing
Rapid and Reliable Drug Screening
Jal Medical proudly presents the iCARE DOA 10 Panels Rapid Screen Test, a configurable solution designed for rapid, qualitative, and competitive binding immunoassay. This cutting-edge drug testing kit is specifically crafted for the determination of configured drugs and their metabolites in urine, surpassing the cutoff level of 50ng/mL. Our test is not intended for monitoring drug levels but excels in screening urine for the presence of configured drugs and their metabolites.
DOA 10 Panels Rapid Screen Test Key Features:
- Conforms to International Standards: Our iCARE DOA 10 Panels Rapid Screen Test adheres to the drug of abuse test standards set by the USA, Europe, and international regulatory bodies, ensuring reliability and accuracy.
- Versatile Design Specifications: With a variety of design specifications available, you can choose the configuration that best suits your requirements, allowing flexibility and customization.
- High Specificity: Boasting high specificity, our test delivers precise results, reducing the chances of false positives and ensuring confidence in the screening process.
- User-Friendly and Swift: The iCARE DOA 10 Panels Rapid Screen Test is incredibly easy to use, providing results in just 5 minutes. Its simplicity makes it suitable for various settings, including Point-of-Care Testing (POCT).
- Comprehensive Drug Panel: Tests for a broad range of chemicals, including AMP, BAR, BZO, BUP, COC, MDMA, KAN, THC, MTD, OPI, OCD, PCP, TCA, covering the most common configured drugs.
- Storage and Portability: Designed to be stored at room temperature, our test is easy to carry, making it convenient for on-the-go testing scenarios.
Specifications of DOA 10 Panels Rapid Screen Test:
- Model Name: Refer to Catalogue
- Packing: Available in 50T or 100T per box
- Specimen: Urine
- Type of Test: Combination of any 10 of the following drugs: Amphetamine (AMP), Barbiturates (BAR), Benzodiazepines (BZO), Buprenorphine (BUP), Cocaine (COC), Ecstasy (MDMA), Ketamine (KAN), Marijuana (THC), Methadone (MTD), Opiate (OPI), Oxycodone (OCD), Phencyclidine (PCP), Tricyclic Antidepressant (TCA)
- Specificity: 100%
- Sensitivity: 90%
- Minimum Order Quantity (MOQ): 2,000
- Shelf Life: 24 months from the date of production
- Private Labeling: Yes, with a minimum order quantity of 5,000 units
- Certification: CE, FDA, 510K for most similar products
Jal Medical takes pride in supplying the iCARE DOA 10 Panels Rapid Screen Test to a total of 57 African countries, as well as catering to the drug testing needs of Caribbean countries and Central Asian regions. Trust in our commitment to quality, precision, and global compliance for your drug screening requirements.